Go to content Go to the menu Go to the search

PartnersSorbonne Université
Quick access, personalized services
Immunological Biotherapies: Concepts and Development

Contact us

Miriam MERAD (miriam.merad @ mssm.edu) 

François LEMOINE (francois.lemoine @ sorbonne-universite.fr)

Roger CHAMMAS (rchammas @ usp.br)

Rachel Fabre (rachel.fabre @ sorbonne-universite.fr) -  Secretary



Miriam Merad, MD, PhD, is a Professor of Oncological Science and of Medicine (Hem/Onc division) at the Icahn School of Medicine at Mount Sinai in New York.

Dr. Merad’s laboratory studies the mechanisms that regulate the development and function of innate myeloid cells including dendritic cells and macrophages. One of the major goals of her laboratory is to identify the contribution of these cells to the development and progression of tumor cells.



François Lemoine, MD, PhD, is a Professor of Immunology at CIMI center in Paris and as the Director of the teaching department of Immunology, Faculty of Medecine - Sorbonne Universite, and National coordinator of the inter-universitary diploma (DIU) "Immunology and Biotherapies".

Pr. Lemoine’s team is working on Head and Neck Squamous Cell Carcinoma and especially in the development of innovative biotherapies (cancer vaccines and combinational therapies).




Roger Chammas, MD-PhD, is currently Professor of Oncology at Universidade de São Paulo.

R. Chammas is presently chair of the graduate Program of Oncology at Universidade de São Paulo and President of the Instituto do Câncer do Estado de São Paulo, a specialized Center for Cancer Research associated with the University. His research focuses on the functional significance of aberrant glycosylation patterns often found in tumors, with emphasis on the role of glycan binding proteins, such as galectins, in tumor cell interactions with their microenviroment and in the control of tumor-associated vascular function.



Traductions :